126 related articles for article (PubMed ID: 10330538)
1. [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].
Miravitlles M; Murio C; Guerrero T; Segú JL
Arch Bronconeumol; 1999 Apr; 35(4):173-8. PubMed ID: 10330538
[TBL] [Abstract][Full Text] [Related]
2. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.
Miravitlles M; Mayordomo C; Artés M; Sánchez-Agudo L; Nicolau F; Segú JL
Respir Med; 1999 Mar; 93(3):173-9. PubMed ID: 10464874
[TBL] [Abstract][Full Text] [Related]
4. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases.
Anthonisen NR; Woodlrage K; Manfreda J
Can Respir J; 2005 Mar; 12(2):69-74. PubMed ID: 15785794
[TBL] [Abstract][Full Text] [Related]
5. [Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols].
de Miguel Díez J; Izquierdo Alonso JL; Rodríguez González-Moro JM; de Lucas Ramos P; Molina París J
Arch Bronconeumol; 2003 May; 39(5):195-202. PubMed ID: 12749801
[TBL] [Abstract][Full Text] [Related]
6. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
7. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
8. Physician perceptions and management of COPD.
Kesten S; Chapman KR
Chest; 1993 Jul; 104(1):254-8. PubMed ID: 8325079
[TBL] [Abstract][Full Text] [Related]
9. Which patients are prescribed inhaled anti-asthma drugs?
Roberts SJ; Bateman DN
Thorax; 1994 Nov; 49(11):1090-5. PubMed ID: 7831622
[TBL] [Abstract][Full Text] [Related]
10. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
11. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort.
Jochmann A; Scherr A; Jochmann DC; Miedinger D; Török SS; Chhajed PN; Tamm M; Leuppi JD
Swiss Med Wkly; 2012; 142():w13567. PubMed ID: 22481636
[TBL] [Abstract][Full Text] [Related]
12. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
13. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P; Chong J; Cates CJ
Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
[TBL] [Abstract][Full Text] [Related]
14. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
[TBL] [Abstract][Full Text] [Related]
15. Geographic differences in clinical characteristics and management of COPD: the EPOCA study.
Miravitlles M; Murio C; Tirado-Conde G; Levy G; Muellerova H; Soriano JB; Ramirez-Venegas A; Ko FW; Canelos-Estrella B; Giugno E; Bergna M; Chérrez I; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):803-14. PubMed ID: 19281096
[TBL] [Abstract][Full Text] [Related]
16. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
17. Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand.
Parkin L; Barson D; Zeng J; Horsburgh S; Sharples K; Dummer J
Respirology; 2018 Jun; 23(6):583-592. PubMed ID: 29265705
[TBL] [Abstract][Full Text] [Related]
18. Treatment of decompensated chronic obstructive pulmonary disease in the emergency department--correlation between clinical features and prognosis.
Murata GH; Gorby MS; Chick TW; Halperin AK
Ann Emerg Med; 1991 Feb; 20(2):125-9. PubMed ID: 1996791
[TBL] [Abstract][Full Text] [Related]
19. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
20. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
